- Report
- August 2026
- 446 Pages
Global
From €5252EUR$5,850USD£4,496GBP
- Report
- August 2026
- 174 Pages
Global
From €5252EUR$5,850USD£4,496GBP
- Report
- June 2026
- 150 Pages
Global
From €4264EUR$4,750USD£3,651GBP
- Report
- February 2026
- 150 Pages
Global
From €3366EUR$3,750USD£2,882GBP
- Report
- May 2026
- 147 Pages
Global
From €3546EUR$3,950USD£3,036GBP
- Report
- November 2025
- 148 Pages
Global
From €3546EUR$3,950USD£3,036GBP
- Report
- February 2026
- 200 Pages
Global
From €4484EUR$4,995USD£3,839GBP
- Report
- October 2025
- 160 Pages
Global
From €2837EUR$3,160USD£2,429GBP
€3546EUR$3,950USD£3,036GBP
- Report
- October 2025
- 160 Pages
Global
From €2837EUR$3,160USD£2,429GBP
€3546EUR$3,950USD£3,036GBP
- Report
- April 2026
- 112 Pages
Global
From €3500EUR$4,176USD£3,101GBP
- Report
- February 2026
- 187 Pages
Global
From €4354EUR$4,850USD£3,727GBP
- Report
- February 2026
- 207 Pages
Global
From €4354EUR$4,850USD£3,727GBP
- Report
- November 2025
- 150 Pages
Global
From €4354EUR$4,850USD£3,727GBP
- Report
- December 2025
Global
From €6733EUR$7,500USD£5,764GBP
- Report
- December 2025
Global
From €6733EUR$7,500USD£5,764GBP
- Report
- March 2026
- 99 Pages
Europe
From €3546EUR$3,950USD£3,036GBP
- Report
- March 2026
- 94 Pages
Asia Pacific
From €3546EUR$3,950USD£3,036GBP
- Report
- March 2026
- 90 Pages
North America
From €3097EUR$3,450USD£2,651GBP
- Report
- December 2025
- 92 Pages
Europe
From €5382EUR$5,995USD£4,607GBP
- Report
- November 2025
- 67 Pages
North America
From €5382EUR$5,995USD£4,607GBP

The Transcatheter Mitral Valve (TMV) is a type of cardiovascular device used to treat mitral valve regurgitation, a condition in which the mitral valve does not close properly, allowing blood to flow backward into the left atrium. TMV is a minimally invasive procedure that involves the insertion of a prosthetic valve into the heart through a catheter. This procedure is an alternative to open-heart surgery, which is more invasive and carries a higher risk of complications.
TMV is a rapidly growing market, with a number of companies developing and marketing products. These companies are focused on improving the safety and efficacy of TMV procedures, as well as expanding the range of patients who can benefit from the procedure. Companies in the TMV market include Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, and Neovasc. Show Less Read more